Because the number of BRCA1/2 genetic testing performed in our department so small before the approval of BRACAnalysis® for HBOC in primary breast cancers, we did not have enough data to discuss the association between the presence of BRCA1/2 mutation carrier and their prognosis. The gene discussed is BRCA1; the disease is breast cancer.